Drilldown: Medicines

25N-NBOMe (1) · 2C-B-FLY (1) · 2C-C (1) · 2C-I (1) · 2C-T-2 (1) · 4-HO-DET (1) · 4-HO-DiPT (1) · 4-HO-DPT (1) · 4-HO-EPT (1) · 4-HO-MET (1) · 4-HO-MiPT (1) · 5,6-MDO-DMT (1) · 5-MeO-DiPT (1) · 5-MeO-MiPT (1) · Allylescaline (1) · DET (1) · DOI (1) · DOM (1) · DPT (1) · EPT (1) · Escaline (1) · Liraglutide (1) · MET (1) · Methallylescaline (1) · MiPT (1) · Proscaline (1) · Psilocin (1) · TMA-2 (1)

None (27) · Victoza (T2DM), Saxenda (obesity) (1)

Classic Psychedelic (26) · Phenethylamine (12) · Research material (26) · Tryptamine (15) · [[GLP-1 receptor agonist]] · [[Antidiabetic medicines|Antidiabetic]] · [[Anti-obesity medicines|Anti-obesity]] · [[Cardiovascular risk reduction]] agent (1)

None · 5-HT2A agonist · GABAA positive allosteric modulator · Monoamine releasing agent · CB1/CB2 agonist · Potent mu-opioid receptor agonist · Sodium channel blocker · Dopamine/norepinephrine reuptake inhibitor · GABAA potentiator; NMDA antagonist · Phenothiazine D2 antagonist · Potent 5-HT2A agonist · 5-HT1B/1D agonist · LSD analogue; 5-HT2A agonist · Mu-opioid receptor agonist · Muscarinic receptor antagonist · Prodrug of LSD; 5-HT2A agonist · Selective norepinephrine reuptake inhibitor · GABAA positive allosteric modulator (non-benzodiazepine) · GABAA potentiator and direct activator · Irreversible non-selective MAO inhibitor

Other values:

Search

None (27) · [[Type 2 diabetes mellitus]] (incl. pediatric ≥10 y) · [[Obesity]] (incl. pediatric ≥12 y) · [[Cardiovascular risk reduction]] in T2DM (1)

None (27) · Victoza: 0.6 mg SC daily × 1 wk'"`UNIQ--ref-00000181-QINU`"' · Saxenda: 0.6 mg SC daily × 1 wk'"`UNIQ--ref-00000182-QINU`"' (1)

None (27) · Pre-filled multi-dose pen (3 mL): Victoza 6 mg/mL (0.6 / 1.2 / 1.8 mg per day);'"`UNIQ--ref-00000183-QINU`"' Saxenda 6 mg/mL (0.6 / 1.2 / 1.8 / 2.4 / 3.0 mg per day)'"`UNIQ--ref-00000184-QINU`"' (1)

None (27) · 1.8 mg/day SC (Victoza, T2DM)'"`UNIQ--ref-00000185-QINU`"' · 3.0 mg/day SC (Saxenda, obesity)'"`UNIQ--ref-00000186-QINU`"' (1)

None (27) · Subcutaneous (abdomen (1) · thigh (1) · upper arm); same time each day (1) · with or without food'"`UNIQ--ref-00000187-QINU`"' (1)

None (27) · Glycemic effect within days; weight effect over weeks to months'"`UNIQ--ref-00000188-QINU`"' (1)

None (27) · ~24 h (daily dosing)'"`UNIQ--ref-00000189-QINU`"' (1)

None (27) · ~13 hours'"`UNIQ--ref-0000018A-QINU`"' (1)

None (27) · SC ~55%'"`UNIQ--ref-0000018B-QINU`"' (1)

None (27) · Avoid. Discontinue before planned pregnancy.'"`UNIQ--ref-0000018C-QINU`"' (1)

None (27) · Rx-only;'"`UNIQ--ref-0000018D-QINU`"' not a controlled substance (1)